FINKELSTEIN J J

CIK 00011256101 companyBETHESDA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001125610

Recent Transactions

47 trades

Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (Right to Buy)
2022-05-17+600,000→ 600,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2021-08-02+600,000→ 600,000 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2021-06-30$0.20/sh+75,000→ 1,712,991 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Series A Common Stock Warrant (right to buy)
2021-06-30+56,250→ 56,250 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Series B Common Stock Warrant (right to buy)
2021-06-30+56,250→ 56,250 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock Warrant (right to buy)
2020-10-15+20,880→ 20,880 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2020-10-15$10000.00/sh
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2020-06-10+500,000→ 500,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2019-05-15+650,000→ 650,000 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock Warrant (right to buy)
2019-05-13+78,125→ 78,125 total
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2019-05-13$12500.00/sh
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2019-02-27$12500.00/sh
Purchase
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock Warrant (right to buy)
2019-02-27+78,125→ 78,125 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (Right to Buy)
2018-07-17$0.21/sh+250,000→ 250,000 total
Conversion
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2018-07-05−104,456→ 0 total
Conversion
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2018-07-05$0.06/sh+104,456→ 1,637,991 total
Exercise of In-Money
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock Warrant (right to buy)
2017-10-19−20,000→ 0 total
Exercise of In-Money
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2017-10-19$0.15/sh+20,000→ 1,533,535 total
Conversion
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2017-10-19$0.15/sh+125,347→ 1,513,535 total
Conversion
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2017-10-19−125,347→ 0 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2017-09-01+150,000→ 150,000 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2016-12-30−100,000→ 1,388,188 total
Will/Inheritance
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2016-12-01+210,550→ 1,488,188 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2016-03-16+200,000→ 200,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2015-06-30+500,000→ 500,000 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2015-03-25−100,000→ 1,277,638 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2014-09-29$15000.00/sh→ 100,000 total
Disposition to Issuer
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2014-09-29$15000.00/sh→ 0 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2013-07-05$5000.00/sh
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Convertible Promissory Note (right to buy)
2012-10-19$15000.00/sh
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock Warrant (right to buy)
2012-10-19+20,000→ 20,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Option (right to buy)
2012-04-03+35,000→ 35,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Options (right to buy)
2012-01-24+500,000→ 500,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Options (right to buy)
2011-12-02+80,135→ 80,135 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Options (right to buy)
2011-08-03+125,000→ 125,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Options (right to buy)
2010-07-14+125,000→ 125,000 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2010-02-02−500→ 1,377,638 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2009-10-20−12,500→ 1,390,638 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2009-10-20+12,500→ 51,000 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2009-10-20−12,500→ 1,378,138 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Options (right to buy)
2009-10-12+125,000→ 125,000 total
Award
REGENERX BIOPHARMACEUTICALS INC$RGRX
Stock Options (right to buy)
2009-04-10+172,122→ 172,122 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2008-01-09−5,000→ 1,408,138 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2008-01-09−5,000→ 1,403,138 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2004-07-21−25,000→ 1,571,138 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2004-01-05+10,000→ 22,500 total
Gift
REGENERX BIOPHARMACEUTICALS INC$RGRX
Common Stock
2004-01-05−25,000→ 1,596,138 total

Companies

REGENERX BIOPHARMACEUTICALS INC
Director, President and CEO
$RGRX

Recent Filings

Address

C/O REGENERX BIOPHARMACEUTICALS, INC. 3 BETHESDA METRO CENTER, SUITE 630

BETHESDA, MD, 20814

View on SEC.gov